Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1417653761, Iran.
Department of Chemistry, University of Louisiana at Lafayette, Lafayette, LA 70504, USA.
Chem Biodivers. 2022 Apr;19(4):e202100666. doi: 10.1002/cbdv.202100666. Epub 2022 Mar 8.
A novel series of N-phenylacetamide-oxindole-thiosemicarbazide hybrids were synthesized and evaluated for their tyrosinase inhibitory activity. According to tyrosinase inhibition results, all the synthesized compounds showed high tyrosinase inhibitory activity with IC values ranging from 0.8 to 3.88 μM in comparison to positive control kojic acid with IC value of 36.32 μM. Among tested compounds, analog 7o, containing the 2-methyl-4-nitrophenyl on N-phenylacetamide moiety displayed superior tyrosinase inhibition. This compound was around 45-fold more potent than kojic acid. The kinetic analysis of compound 7o demonstrated that this compound is a competitive inhibitor against tyrosinase. Docking study of this compound demonstrated that compound 7o interacted with critical histidine residues within tyrosinase active site.
一系列新型 N-苯基乙酰胺-氧吲哚-硫代卡巴腙杂合被合成出来,并评估了它们的酪氨酸酶抑制活性。根据酪氨酸酶抑制结果,所有合成的化合物都表现出很高的酪氨酸酶抑制活性,IC 值范围在 0.8 到 3.88 μM 之间,而阳性对照曲酸的 IC 值为 36.32 μM。在所测试的化合物中,含有 N-苯基乙酰胺部分的 2-甲基-4-硝基苯基的类似物 7o 显示出优异的酪氨酸酶抑制活性。该化合物的抑制活性比曲酸强约 45 倍。对化合物 7o 的动力学分析表明,该化合物是酪氨酸酶的竞争性抑制剂。该化合物的对接研究表明,化合物 7o 与酪氨酸酶活性部位内的关键组氨酸残基相互作用。